[Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years].

MLA

May, M., et al. “[Adjuvant Autologous Tumour Cell Vaccination in Patients with Renal Cell Carcinoma. Overall Survival Analysis with a Follow-up Period in Excess of More than 10 Years].” Der Urologe. Ausg. A, vol. 48, no. 9, Sept. 2009, pp. 1075–83. EBSCOhost, https://doi.org/10.1007/s00120-009-2044-y.

APA

May, M., Kendel, F., Hoschke, B., Gilfrich, C., Kiessig, S., Pflanz, S., Seidel, M., & Brookman-Amissah, S. (2009). [Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years]. Der Urologe. Ausg. A, 48(9), 1075–1083. https://doi.org/10.1007/s00120-009-2044-y

Chicago

May, M, F Kendel, B Hoschke, C Gilfrich, S Kiessig, S Pflanz, M Seidel, and S Brookman-Amissah. 2009. “[Adjuvant Autologous Tumour Cell Vaccination in Patients with Renal Cell Carcinoma. Overall Survival Analysis with a Follow-up Period in Excess of More than 10 Years].” Der Urologe. Ausg. A 48 (9): 1075–83. doi:10.1007/s00120-009-2044-y.